oxyphenbutazone has been researched along with apomorphine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, KX; Ding, H; Du, DH; Hu, JC; Jiang, HL; Kong, XQ; Li, LC; Liu, JQ; Luo, C; Zhu, MR | 1 |
2 other study(ies) available for oxyphenbutazone and apomorphine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors.
Topics: Apomorphine; Enhancer of Zeste Homolog 2 Protein; Ergonovine; Fluorescence Polarization; High-Throughput Screening Assays; Humans; Hydrogen-Ion Concentration; Limit of Detection; Nifedipine; Oxyphenbutazone; Peptide Fragments; Polycomb Repressive Complex 2; Protein Binding; Protein Multimerization; Temperature | 2018 |